Leaderboards/Ophthalmology and Eye Disorders

Ophthalmology and Eye Disorders

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Malik Moledina
Queen Victoria Hospital
2
J.V. Pérez-Moreiras
Universidade de Santiago de Compostela
3
Anne Stankewitz
TUM Klinikum
4
Angela M. Chen
Marshall B. Ketchum University
5
Linhan Zhai
Tongji Hospital
6
Roshini Fernando
University of Michigan
7
Cellas A. Hayes
Stanford University
8
С.С. Агзамова
Unknown
9
Zhaohuai Li
Sun Yat-sen University
10
Marija Sarić Matutinović
University of Belgrade

Rising Stars Papers

1
The changing landscape of thyroid eye disease: current clinical advances and future outlook
Eye|2024
56 cit.
2
The impact of arteriolosclerosis on cognitive impairment in decedents without severe dementia from the National Alzheimer's Coordinating Center
Alzheimer s & Dementia|2025
14 cit.
3
Racial ethnic variations in the cardiometabolic determinants and blood pressure of white matter hyperintensities among females—The HABS‐HD Study
Alzheimer s & Dementia|2025
12 cit.
4
Fat-suppression T2 relaxation time and water fraction predict response to intravenous glucocorticoid therapy for thyroid-associated ophthalmopathy
European Radiology|2024
9 cit.
5
Age-dependent interactions of APOE isoform 4 and Alzheimer’s disease neuropathology: findings from the NACC
Acta Neuropathologica Communications|2025
6 cit.
6
Radiological Activity Score (RAS)—MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi‐Ethnic Thyroid Eye Disease Population
Clinical Endocrinology|2025
4 cit.
7
Sex differences in the association of cardiometabolic risk scores and blood pressure measurements with white matter hyperintensities in diverse older adults—HABS-HD
Frontiers in Aging Neuroscience|2025
4 cit.
8
Empowering Early Career Researchers: The Jackson Heart Study Smith Scholars Program
Journal of Racial and Ethnic Health Disparities|2024
3 cit.
9
Brain connectivity in individuals with migraine resets during the headache phase: a whole-brain connectivity study
Brain Communications|2024
3 cit.
10
Analysis of non-cholesterol sterols and fatty acids in patients with graves’ orbitopathy: insights into lipid metabolism in relation to the clinical phenotype of disease
Journal of Endocrinological Investigation|2025
3 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Andrea L. Kossler
Stanford University
2
María P. Maiquez
Unknown
3
Michael Petrides
Montreal Neurological Institute and Hospital
4
Jing Zhang
Jilin University
5
A. Valle González
Christus Santa Rosa Health System
6
Jens A. Petersen
Numerical Method (China)
7
Bhavya Burugapalli
American Academy of Ophthalmology
8
Domenico Micarelli
Unknown
9
Tereza Planck
Lund University
10
Thomas Bernadzikowski
Chesapeake College

Emerging Leaders Papers

1
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease
American Journal of Ophthalmology|2022
82 cit.
2
Teprotumumab-Related Adverse Events in Thyroid Eye Disease
Ophthalmology|2023
36 cit.
3
An Outperforming Artificial Intelligence Model to Identify Referable Blepharoptosis for General Practitioners
Journal of Personalized Medicine|2022
23 cit.
4
T2 Mapping with and without Fat-Suppression to Predict Treatment Response to Intravenous Glucocorticoid Therapy for Thyroid-Associated Ophthalmopathy
Korean Journal of Radiology|2022
19 cit.
5
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease
Ophthalmic Plastic and Reconstructive Surgery|2023
18 cit.
6
Preliminary Diffusion‐Tensor Imaging Evidence for Trans‐Synaptic Axonal Degeneration in Dysthyroid Optic Neuropathy Due to Thyroid‐Associated Ophthalmopathy
Journal of Magnetic Resonance Imaging|2022
17 cit.
7
Aberrant spontaneous brain activity in patients with thyroid-associated ophthalmopathy with and without optic neuropathy: a resting-state functional MRI study
European Radiology|2023
16 cit.
8
Radiomics analysis of the optic nerve for detecting dysthyroid optic neuropathy, based on water-fat imaging
Insights into Imaging|2022
15 cit.
9
Functional and Morphological Brain Alterations in Dysthyroid Optic Neuropathy: A Combined Resting‐State <scp>fMRI</scp> and Voxel‐Based Morphometry Study
Journal of Magnetic Resonance Imaging|2022
13 cit.
10
Reduction of Teprotumumab-Induced Hearing Loss With Comparable Efficacy Using Half-Dose Therapy
Ophthalmic Plastic and Reconstructive Surgery|2023
11 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Wilmar M. Wiersinga
University of Amsterdam
2
David S. Zee
Johns Hopkins University
3
Joseph L. Demer
University of California, Los Angeles
4
Jes Olesen
Glostrup Hospital
5
Terry J. Smith
University of Michigan
6
David A. Robinson
UK Centre for Ecology & Hydrology
7
Ian S. Curthoys
The University of Sydney
8
Peter J. Goadsby
King's College London
9
J. Gert van Dijk
Leiden University
10
Jonathan M. Holmes
University of Arizona

Current Senior Leaders Papers

1
The International Classification of Headache Disorders: 2nd edition
The Lancet Neurology|2003
5.1k cit.
2
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
Thyroid|2011
2.9k cit.
3
A Report on the Journal 2004
Cephalalgia|2004
2.4k cit.
4
The International Classification of Headache Disorders
Headache The Journal of Head and Face Pain|2008
2.3k cit.
5
Preface to the Second Edition
Cephalalgia|2004
2.1k cit.
6
Cost of disorders of the brain in Europe 2010
European Neuropsychopharmacology|2011
1.7k cit.
7
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome
Clinical Autonomic Research|2011
1.7k cit.
8
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
Annals of Neurology|1990
1.6k cit.
9
The economic cost of brain disorders in Europe
European Journal of Neurology|2011
1.5k cit.
10
Epidemiology of headache in a general population—A prevalence study
Journal of Clinical Epidemiology|1991
1.5k cit.

Reagents for Ophthalmology and Eye Disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling TechnologyEvidence 65

GATA-6 (D61E4) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ UV375 Conjugate)

#63488$458
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Phospho-MAPKAPK-2 (Thr334) (27B7) Rabbit Monoclonal Antibody (BSA and Azide Free)

#53485$898
View Evidence →
Cell Signaling TechnologyEvidence 66

VCP (7F3) Rabbit Monoclonal Antibody

#2649$157,348
View Evidence →
Cell Signaling TechnologyEvidence 68

Thy1/CD90 (D3V8A) Rabbit Monoclonal Antibody (BSA and Azide Free)

#16836$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

IMPDH1 (E5Z5F) Rabbit Monoclonal Antibody

#35914$161,351
View Evidence →
Cell Signaling TechnologyEvidence 65

GATA-6 (D61E4) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ UV375 Conjugate)

#63488$458
View Evidence →
Cell Signaling TechnologyEvidence 64

AhR (D5S6H) Rabbit Monoclonal Antibody

#83200$173,351
View Evidence →